Disability Related Feature Stories and Live Breaking News

Disability Nexus

Subscribe to Disability Nexus : eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Disability Nexus : homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Latest News from Disability Nexus
Add exhibitor profile for Adamis Pharmaceuticals Corporation to the beginning of list of 22nd Annual ROTH OC Growth Stock Conference exhibitor profiles in this release.
22nd Annual ROTH OC Growth Stock Conference takes place March 15 - 17, 2010 at The Ritz Carlton in Dana Point, CA.
New Locations Open in Southfield and Grand Rapids
"Fight Hunger. Give Hope." Program to Raise Money for Area Food Pantries
Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it will be exhibiting its over-the-counter (OTC) and prescription pain relievers...
- Vimpat demonstrated significantly greater seizure reduction versus placebo when added to other antiepileptic drugs (AEDs).
Curriculum Advantage Inc.’s Classworks® comprehensive K-12 instructional software has received an official endorsement from the Council of Administrators of Special Education (CASE). A division of the Council for Exceptional Children, CASE is an inter...
Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the year was $262 million, up 46% from $179...
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE: SSS) wishes to announce the acceptance and publication of the paper entitled "The Beta-hCG + Erythropoietin in Acute Stroke ( BETAS) Study" by the journal "Stroke", on March 8, 2010. This paper was authored by Dr. Stev...
Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced fiscal 2010 third quarter financial results today for the three and nine month periods ended January 31, 2010.
Momentum Continues for Nonprofit Market's Most Advanced Social Networking Application for Special Event Fundraising
AIT Co-founder Skip Kingston, Ph.D., Instrumental to Achieving R&D Excellence
Abbott (NYSE: ABT) and Facet Biotech Corporation (Nasdaq: FACT) announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline. Abbott will acquire Facet for US$27 per share in cash for a net transaction value of appr...
Provides Promising Biologic Intended to Treat Multiple Sclerosis and Compounds that Complement Abbott's Existing Diverse Oncology Program
The Multiple Sclerosis Association of America (MSAA) encourages everyone to take time this March to learn about multiple sclerosis (MS) and discover all of the programs and services MSAA offers to everyone affected by MS.
Brookdale Care, one of the UK's leading providers of specialist hospital, residential and supported living services for people living with Autistic Spectrum Disorders (ASD), has welcomed the publication of "Rewarding and fulfilling lives: The strategy for adults with autism in England ...
AbleNet, Inc. – USA’s Vice President of International Business, Adam Wing, will be making two presentations in Dubai. The Dubai Autism Center and the Dubai International Rehabilitation Forum have Wing presenting on March 16, 2010 on assistive technology solu...
Using magnetoencephalography (MEG), Elekta Neuromag system will help MIT researchers unlock mysteries of normal and abnormal brain function
CommVault (NASDAQ: CVLT):
A crew of artists with MS will travel each week to a new location selected by an online voting community to capture a video story that adds to the reality mosaic
Companies Use NI Software and Hardware to Quickly Develop Physical Prototypes to Prove Inventions
Thousands will unite for autism at the 8th annual Los Angeles Walk Now for Autism Speaks at the Pasadena Rose Bowl, Saturday, April 24, 2010.
Emerging Author Explores Spirituality and Ability to Positively Affect Change in Metaphysical Journey
Isis' first drug to treat neurodegenerative disease enters clinical trials
a safe and effective non-drug option for the self-treatment of psoriasis in the privacy and convenience of a patient's home. LMD introduced Levia at the 68th Annual Meeting of the American Academy of Dermatology (AAD), Booth Number 2807, Miami Beach Convention Center, Miami, Florida.
Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a specialty clinical development pharmaceutical company targeting CNS diseases, today announced its results for the year ended December 31, 2009. Unless specified otherwise, all amounts are in Canadian dollars.